CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
Sakiko Hiraoka, Shiho Takashima, Yoshitaka Kondo, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Seiji Kawano, Keita Harada, Jun Kato, Hiroyuki Okada
Intest Res. 2018;16(1):75-82.   Published online January 18, 2018
DOI: https://doi.org/10.5217/ir.2018.16.1.75

Excel Download

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
Intestinal Research. 2018;16(1):75   Crossref logo
Link1 Link2 Link3

Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients
American Journal of Gastroenterology. 2013;108(4):583-593   Crossref logo
Link1 Link2 Link3 Link4

Anti–Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery
Clinical Gastroenterology and Hepatology. 2014;12(9):1503-1506   Crossref logo
Link1 Link2

PG111 A COST-EFFICACY ANALYSIS MODEL FOR PHYSICIAN ADMINISTERED ANTI-TUMOR NECROSIS FACTOR AGENTS IN CROHN'S DISEASE
Value in Health. 2008;11(6):A521   Crossref logo
Link1 Link2

Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies
Pediatric Gastroenterology, Hepatology & Nutrition. 2020;23(2):121   Crossref logo
Link1 Link2 Link3

The effect of monoclonal anti-tumor necrosis factor-antibody cA2 on coagulation- and fibrinolytic parameters in patients with active Crohn's disease
Gastroenterology. 1995;108(4):A838   Crossref logo
Link1 Link2

864 Efficacy of Vedolizumab Induction Therapy in Patients With Crohn's Disease Who Have Experienced Tumor Necrosis Factor Antagonist Failure or Are Tumor Necrosis Factor Antagonist Naive
Gastroenterology. 2014;146(5):S-149   Crossref logo
Link1 Link2

Fistulizing and Stricturing Crohn's Disease
Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;195-200   Crossref logo
Link1 Link2

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease
Gastroenterology. 1997;113(3):1042-1043   Crossref logo
Link1 Link2

Postoperative Anti-TNF Therapy in the Management of Crohn's Disease
Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;201-205   Crossref logo
Link1 Link2